The Pfizer company claimed that Americans would receive the Corona vaccine by the end of 2020.
Pfizer Incorporated CEO Albert Borla said that the company would bring the vaccine of Covid-19 before the end of this year. Americans will be given the coronavirus virus vaccine before the end of the year 2020.
- Last Updated:September 14, 2020, 1:44 PM IST
Pfizer and Bioentec lead in vaccine competition
New York-based Pfizer and Germany’s BioNotech are seen to be at the forefront of developing a coronovirus vaccine. Along with them, Modern Inc and AstraZeneca PLC are also two important names in this race. Pfizer Inc. CEO Albert Borla said he had a 60% chance of knowing the efficacy of the experimental vaccine by the end of October. The timing of clinical trials results depends on the maximum number of people involved in the study to be corona to calculate the time. Only the positive result will clear the way for approval.
People from this category will be included in the clinical trialPfizer and BioNotech have increased the number of clinical trial participants to include more people from different backgrounds. The two companies said in a statement on Saturday that they are expecting to recruit 30,000 patients in its final phase clinical trial this week. With this, both companies are increasing their target to 44 thousand patients, which will include persons from 16 years of age to HIV and Hepatitis B and Hepatitis C infected persons.
Also read: Microsoft could not buy TickTock, cleared the way for Oracle
Trump claimed, said- PM Modi praised my work on Coronavirus
More than 3 lakh cases a day were found in the world, lockdown again in Israel
Borla said in an interview on CBS that he would also focus on recruiting non-white people, including African Americans and Latino, in a late-stage trial in the coming weeks. Currently, 60% of the people who participate in this study are white and 40% are non-white. In the future, 44 percent old people will be a part of it.